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Critical role of C/EBPd and C/EBPb factors in the stimulation of the
cyclooxygenase-2 gene transcription by interleukin-1b in articular
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The activity of the [2831; 1103] promoter of the human cyclooxygenase-2 gene in cultured rabbit chondrocytes
is stimulated 2.9 ^ 0.3-fold by interleukin-1b and this stimulation depends on [2132; 2124] C/EBP binding-
and [2223; 2214] NF-kB binding-sites. The C/EBPb and C/EBPd factors bind to the [2132; 2124] sequence.
The [261; 253] sequence is also recognized by C/EBPb and C/EBPd as well as USF. Mutation of the whole
[261; 253] sequence abolished the stimulation of transcription but single mutations of the C/EBP or USF site
did not alter the activity of the promoter, suggesting that the factors bound to the proximal [261; 253] sequence
interact with different members of the general transcription machinery. The [2223; 2214] site binds only the
p50/p50 homodimer and a non-rel-related protein, but not the transcriptionally active heterodimer p50/p65. The
p50/p50 homodimer could interact with the C/EBP family members bound to the [2132; 2124] sequence for full
stimulation of the COX-2 transcription by interleukin-1b in chondrocytes. By contrast, the [2448; 2449]
sequence binds with a low affinity both the p50/p50 homodimeric and p50/p65 heterodimeric forms of NF-kB but
has no role in the regulation of the human COX-2 promoter in chondrocytes.
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Arthritic joints produce large quantities of prostaglandins,
mainly prostaglandin E2 (PGE2). PGE2 may be involved in the
erosion of cartilage and juxtaarticular bone, and the induction
of angiogenesis [1±3]. PG production is initiated by the two
isoforms of cyclooxygenase, COX-1 and COX-2 (reviewed in
[4,5]). These bifunctional enzymes convert arachidonic acid
released from membranes by phospholipases A2 [4] into PGG2
(cyclooxygenase activity) and then PGG2 into PGH2 (hydro-
peroxidase activity). PGH2 is converted into PGE2 by a specific
isomerase. COX-1 is a constitutive enzyme, while COX-2 gene
expression is readily induced by inflammation [5].
Although IL-1a stabilizes COX-2 mRNA in human umbi-
lical vein endothelial cells (HUVEC) [6], most work on the
regulation of COX-2 gene expression emphasizes the role of
several transcription factors, such as NF-kB and C/EBP family
members. NF-kB acts on the human promoter at two putative
sites, one at 2448/2439 and the other at 2223/2214
(Fig. 1A). The proximal site is involved in the stimulation of
COX-2 gene transcription by hypoxia in HUVEC [7]. The
mouse sequence homologous to the human distal site takes part
in induction of the activity of the rodent promoter by TNFa
in the osteogenic cell line MC3T3-E1 [8], and the binding of
NF-kB to both the proximal and distal sites is correlated with
the stimulation of COX-2 gene expression by IL-1b in human
rheumatoid synoviocytes [9]. However, the mouse distal NF-kB
site does not contribute to the induction of the promoter activity
by LPS in RAW 264.7 macrophages [10] and mutation of the
rat homologous sequence does not suppress the stimulation of
the activity of the rat COX-2 promoter by TNFa in rat vascular
smooth muscle cells [11], or the basal promoter activity in the
pancreatic islet cell line HIT-T15 [12].
C/EBP factors are also involved in regulating the activity of
the COX-2 promoter. There is a C/EBP binding site on the
human promoter at positions 2132/2124 downstream of an
adjacent AP-2 site, which plays a role in the induction of the
promoter activity by LPS in vascular endothelial cells [13]. The
rat homolog of this C/EBP binding site is involved in cAMP-
dependent regulation of COX-2 transcription by FSH and LH in
rat granulosa cells [14], and in basal promoter activity in the
pancreatic islet cell line HIT-T15 [12] and in the mouse skin
[15]. The C/EBP family contains three main activating
members, C/EBPa, C/EBPb and C/EBPd, which all recognize
the same DNA sequence. C/EBPa is involved in hepatic and
adipogenic differentiation, while C/EBPb and C/EBPd are
responsible for the induction of several acute phase genes by
IL-6 in the liver. Treating mice with LPS increases the
transcription rate of the C/EBPb and C/EBPd genes in their
kidneys and livers [16]. Phosphorylation of C/EBPb by MAP
kinases also increases the transactivating ability of this factor
[17]. C/EBPa, C/EBPb and C/EBPd proteins have a common
structure, with an N-terminal domain bearing the transactiva-
tion domain, a basic DNA-binding domain and a C-terminal
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domain containing a leucine zipper, which allows the homo- or
heterodimerization of these factors [18].
Finally, the activities of the rodent and human COX-2
promoters are regulated by a proximal element that is located
20 bp upstream of the TATA box, but there are conflicting
data on the role and the nature of the proteins bound to this
promoter [10±14,19±23]. This element contains a perfect
E-box 5 0-CACGTG-3 0 in the mouse and rat promoters, but the
homologous sequence on the human promoter differs by one
base pair [19] (Fig. 1). An ATF/CRE 5 0-CGTCAC-3 0 overlaps
the E-box in the murine and human promoters [20,21].
Different factors therefore bind to this proximal element,
depending on the species and on the cell. ATF and CREB
family members bind to the murine sequence in NIH3T3 cells,
but the response to mitogenic stimuli in these cells is mediated
by c-jun, which heterodimerizes with the ATF family members
[22,23]. The rat COX-2 promoter is also not recognized by
ATF/CRE activities in ovarian granulosa cells, but the E-box
binds USF factors and is required for basal transcription and its
stimulation by hormones [19]. The ATF/CRE sequence is also
required for basal expression of the human COX-2 gene in the
macrophage cell line U937 [21] and actually binds C/EBPd
instead of ATF/CREB family members in vascular endothelial
cells transfected by C/EBP expression vectors [13]. Both this
sequence and the distal 2132/2124 C/EBP binding site are
required for the human COX-2 promoter to be induced by LPS
in these cells [13]. In contrast, the E-box is not required for
induction of the promoter activity by LPS in RAW 264.7
macrophages while mutation of the CRE sequence drastically
reduces both the basal and stimulated transcription activities
[10].
IL-1b causes expression of both the type IIA secreted phos-
pholipase A2 (sPLA2-IIA) [25] and the COX-2 genes [24] in
chondrocytes. Arachidonic acid may be provided to COX-2
by sPLA2-IIA, and we have demonstrated that the binding of
sPLA2-IIA to chondrocyte membranes correlates with increased
PGE2 production [24]. COX-2 and sPLA2-IIA are therefore
functionally linked. We have also shown that C/EBPd plays a
critical role in the activation of the sPLA2-IIA promoter by
IL-1b in primary cultures of rabbit chondrocytes [25]. The
present study was undertaken to determine whether both
sPLA2-IIA and the COX-2 gene can be induced by the same
transcription factors in response to IL-1b and whether these
factors may be putative therapeutic targets at which to block
inflammation. We examined the roles of the C/EBP family
members and their collaboration with c-rel family members in
the regulation of COX-2 gene transcription in chondrocytes. We
also characterized other transcription factors, specifically the
USF proteins, that recognize regulatory elements in the human
COX-2 promoter and determined the contributions of each of
these cis-elements to IL-1b-stimulated transcription.
M A T E R I A L S A N D M E T H O D S
Materials
Restriction enzymes, T4 kinase, ligase and Taq polymerase
were purchased from Biolabs (USA). Oligonucleotides were
provided by Oligoexpress (France). Materials for cell culture
and protein molecular weight markers were from Sigma (USA)
(Dulbecco's modified Eagle's medium, HAM's F12 medium,
fetal bovine serum, Hepes, trypsin, glutamine, penicillin±
streptomycin), Gibco BRL (Gey medium) and Costar (USA)
(flasks and Petri dishes). The b-galactosidase expression vector
CMVb-gal was obtained from Clontech (USA), and poly(dI´dC)
and deoxynucleotides from Pharmacia (Sweden). Radioactive
Fig. 1. IL21b stimulation of the transcription activities induced by various 5 0 deleted fragments of the human COX-2 promoter in primary cultures of
rabbit chondrocytes. (A) Locations of the putative NF-kB and C/EBP binding sites on the human COX-2 promoter. The sequences of the putative binding
sites are indicated in frames as are their locations on the promoter and the locations of the COX2-A, COX2-B, COX2-C and COX2-D oligonucleotides. The
regulatory proximal element COX2-A is also described as a ATF/CRE and E-box like sequence. The sense strand of the [2132; 2124] sequence (COX2-B)
fits with the C/EBP consensus site 5 0-TT/GNNGNAAT-3 0. By contrast the [261; 253] sequence (COX2-A) is homologous to the C/EBP consensus site in
the antisense orientation. (B) Chondrocytes at 60% confluence were transfected by the calcium phosphate coprecipitation method using 12 mg of the various
CAT constructs, 2.5 mg of the CMV-b-gal expression vector; 24 h after transfection, the cells were incubated with or without IL-1b (10 ng´mL21) for an
additional 24 h and then harvested for measurement of CAT and b-galactosidase activities. The percentages of stimulation by IL-1b were calculated relative
to the transcription activity obtained for each construct without IL-1b. Results are expressed as the means ^SEM of four independent transfections
performed in duplicate.
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products were supplied by Amersham (UK). Collagenase,
hyaluronidase and trypsin for preparing monolayers of rabbit
chondrocytes were supplied by Boehringer Mannheim (France).
The antibodies against the NK-kB subunits p50 and p65 and the
C/EBP family members C/EBPa, C/EBPb and C/EBPd were
provided by Santacruz Biotechnology (USA). The antibodies to
USF1 and USF2 were gifts from M. Raymondjean (ICGM
Cochin, Paris, France).
Chondrocyte cultures and transfections
Female 3-week-old Fauve de Bourgogne rabbits were killed
and the shoulders, knees and femoral heads were dissected out
under sterile conditions [26]. The articular cartilage was
removed, cut into small pieces, and digested at 37 8C with
0.05% hyaluronidase in Gey medium for 15 min, then with
0.25% trypsin for 30 min, and lastly with 0.2% collagenase for
90 min. The resulting chondrocytes were washed in HAM's
F12 medium without fetal bovine serum for 60 min, suspended
in HAM's F12 medium supplemented with 10% fetal bovine
serum and seeded into 60 mm dishes (1.5  105 cells per dish).
The cells were maintained at 37 8C in 5% CO2 and the culture
medium was changed every 2±3 days. The cells reached
preconfluency within 6±7 days.
Chondrocytes were transfected using the calcium phosphate
DNA coprecipitation method [27]. Cells were placed in DMEM
and incubated with the transfection mixture containing 12 mg
pUC-SH-CAT constructs and 2.5 mg of plasmids bearing the
b-galactosidase gene, for 4 h. They were then shocked with
HBS buffer (21 mm Hepes, pH 7.1, 16 mm dextrose, 0.8 mm
NA2HPO4, 5 mm KCl, and 137 mm NaCl) containing 15%
glycerol for 90 s. The treated cells were incubated for 20 h in
HAM's F12 without fetal bovine serum and grown for an
additional 24 h in HAM's F12 without fetal bovine serum, with
or without IL-1b (10 ng´mL21). The harvested cells were lysed
by incubation with 50 mL 100 mm Tris pH 7.8, 0.7% NP40 for
15 min at 4 8C. CAT activities were measured by the two-liquid
phases method [28]. b-Galactosidase activities were measured
to normalize variations in transfection efficiency. Transfection
experiments were performed in duplicate and repeated four
times with two different preparations of plasmids.
Plasmid constructions
The various 5 0 deleted fragments of the human COX-2 pro-
moter from the 2831, 2571, 2491, 2261, 2170, 281 to the
1103 positions were amplified by PCR and inserted into the
pCATBASIC plasmid (Promega, USA) upstream of the CAT
gene. The [2223; 2214] 5 0-GGGACTACCC-3 0 proximal puta-
tive NF-kB site on element COX2-C was mutated into the
5 0-GGGACTCGAG-3 0 sequence in the [2261; 1103]-Cmut
construct. This mutation introduced an additional XhoI site. The
[2132; 2124] 5 0-GGGCTTACGCAAT-3 0 putative distal C/
EBP binding site on the COX2-B element was replaced by the
GGGGTGAATTCGAT-3 0 sequence, which contains an EcoRI
site, and the mutant promoter was cloned into the
[2261; 1103]-Bmut CAT construct. The whole [262; 250]
5 0-CATTTCGTCACAT-3 0 sequence of the COX2-A element
was mutated into the 5 0GAATTCGAGCTCG-3 0 in the [2261;
1103]-Amut1 CAT plasmid, whereas the partially mutated
5 0-CAACGCGTCACAT-3 0 and 5 0-CATTTCGTCAGCT-3 0
sequences were inserted into the [2261; 1103]-Amut2 and
[2261; 1103]-Amut3 CAT plasmids.
The PHD expression vectors containing the C/EBPb and
C/EBPd cDNAs were a gift from G. Ciliberto (IRBM, Rome,
Italy). The expression vector of the undegradable mutant of
I-kB was generously given by A. IsraeÈl (Paris, France).
Preparation of nuclear extracts and cell lysates
Nuclear extracts of chondrocytes were prepared as previously
described [29]. Briefly, confluent cells from three P100 dishes
were grown in HAM's F12 without fetal bovine serum and then
incubated in HAM's F12 with or without IL-1b (10 ng´mL21)
for 24 h. They were then washed and scraped off in NaCl/Pi.
The cells were centrifuged at 1500 g for 5 min and the pellet
was suspended in 500 mL buffer A (5 mm Hepes pH 7.9,
1.5 mm MgCl2, 10 mm KCl, 0.5% NP40, 0.5 mm dithiothreitol,
0.1 mm phenylmethanesulfonylfluoride, 5 mg´mL21 leupeptin,
50 mm NaF). The cells were incubated at 4 8C for 15 min,
centrifuged at 6000 g for 10 min, and the pellet suspended in
100 mL buffer C (20 mm Hepes pH 7.9, 25% glycerol, 0.5 m
NaCl, 1.5 mm MgCl2, 0.5 mm EDTA, 0.5 mm dithiothreitol,
0.5 mm phenylmethanesulfonylfluoride, 5 mg´mL21 leupeptin,
50 mm NaF). The nuclei were lysed by pipetting up and down
four times and incubating for 30 min at 4 8C. The lysates were
centrifuged at 100 000 g for 30 min at 4 8C in a TLC centrifuge
(Beckman, USA). The supernatants were collected and the
protein concentrations were measured according to Kalb &
Berlohr [30]. The nuclear protein batches were stored at 280 8C.
Lysates of COS-1 cells were prepared 40 h after transfection of
the cells with the C/EBP expression vectors according to
Olivier et al. [31].
Bandshift assays
The COX2-D (5 0-CGGGAGAGGGGATTCCCTGCGCC-3 0),
COX2-C (5 0-CAGGAGAGTGGGGACTACCCCCTCTGCTCC-
3 0), COX2-B (5 0-CACCGGGCTTACGCAATTTTTTTAA-3 0),
COX2-A (5 0-AGAAACAGTCATTTCGTCACATGGGCTTGG-
3 0) oligonucleotides corresponding to the regulatory elements
of the human COX-2 promoter and the KBEwt oligonucleotide
(5 0-ACAGAGGGGACTTTCCGAGAG-3 0) corresponding to the
enhancer of the light chain k gene [32] were used as probes.
These double-stranded oligonucleotides (100 ng) were labeled
using T4 kinase and 50 mCi [g-32P] ATP. Free nucleotides were
separated from the labeled probe on a Sephadex G50 column.
The specific activity of the probe was estimated by spotting
1 mL of the labeling mixture (before the G50 column) onto a
TLC plate, separating the labelled probe and free nucleotide by
chromatography and counting them. The specific activities were
1±2  108 cpm´mg21. Chondrocyte nuclear extracts (6±9 mg)
were incubated at 4 8C for 15 min in a 20-mL reaction solution
containing 25 mm Hepes pH 7.6, 8% Ficoll, 40 mm KCl, 5 mm
MgCl2, 1 mm dithiothreitol, and 3 mg of double-stranded
poly(dI´dC). When double-stranded competitor oligonucleo-
tides were used, they were added in a volume of 1 mL and the
reaction mixture was incubated with the nuclear extracts at 4 8C
for 15 min before adding the probe. The competitors used in
bandshift assays were the D-Alb oligonucleotide 5 0-TGGTAT-
GATTTTGTAATGGGGTAGGA-3 0, which corresponds to the
element D of the murine albumin promoter and binds C/EBP
proteins [33], and the USF oligonucleotide 5 0-TGGTCACGT-
GGCCTACACCTATAA-3 0, which corresponds to the enhancer
of the murine immunoglobin heavy chain gene and binds USF
proteins [34]. The sequences of the other oligonucleotides used
as competitors are indicated in the corresponding figures.
Double-stranded oligonucleotide probes (100 000 cpm) were
then added and the incubation was continued for 30 min at
4 8C. Free DNA and DNA±protein complexes were resolved by
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electrophoresis in 5% or 7% polyacrylamide gels in 6.7 mm
Tris/HCl, 3.3 mm sodium acetate, 1 mm EDTA, pH 7.9. The
gels were dried and exposed to X-OMATw film (Kodak, USA).
In supershift experiments, chondrocyte nuclear extracts were
preincubated for 15 min at 4 8C with 1 mL of specific
antibodies.
R E S U LT S
Requirement of the [2261; 281] fragment of the human
COX-2 promoter for stimulation of its activity by IL-1b in
chondrocytes
The human COX-2 promoter contains two putative binding
sites for NF-kB and the C/EBP factors (Fig. 1A). The proximal
putative C/EBP binding sequence is also a putative ATF/CRE
site overlapping an E-box-like sequence. We named the
elements containing the proximal CRE and the distal C/EBP
binding sites COX2-A and COX2-B, respectively, and the
elements enclosing the putative NF-kB sites COX2-C and
COX2-D (Fig. 1A). Primary cultures of rabbit chondrocytes
were transiently transfected by CAT constructs containing
5 0-deleted fragments of the COX-2 promoter to determine
the regions responsible for stimulation by IL-1b. Incubating the
cells with IL-1b for 24 h increased the activity of the
[2831; 1103] fragment of the COX-2 promoter 2.9 ^ 0.3-
fold (Fig. 1B). The stimulation of the promoter activity by
IL-1b was not modified by deletions down to the 2261
position; the last deletion removed the putative distal 2448/
2439 NF-kB binding site (Fig. 1A,B). By contrast, deletion of
the [2261; 2170] fragment, containing the proximal NF-kB
2223/2214 putative binding site, reduced the stimulation of
the transcription activity by IL-1b to 1.6 ^ 0.3-fold, and
deletion of the [2170; 281] fragment, which suppressed the
distal C/EBP binding sites but preserved the CRE, abolished all
induction of transcription by IL-1b (Fig. 1B). This result
indicates that the [2170; 281] fragment, which contains the
[2140; 2116] COX2-B element, is critical for the regulation of
the human COX-2 promoter by IL-1b in chondrocytes and
suggests that the C/EBP factors are involved in this regulation.
In addition, deletion of the [2261; 2170] fragment increased
the basal activity of the COX-2 promoter 2.6 ^ 0.3-fold (data
not shown).
Need for binding of C/EBPb and C/EBPd to the [2140; 2116]
COX-2B element of the human COX-2 promoter for
stimulation of its activity by IL-1b in primary cultures
of rabbit chondrocytes
The oligonucleotide corresponding to the [2140; 2116]
COX2-B element formed two complexes with the chondrocytes
nuclear extracts, B1 and B2, whose intensities were increased
when the cells were first treated with IL-1b (Fig. 2A, compare
lanes 1 and 2). Both these complexes were competed out by
100-fold excesses of the unlabeled COX2-B, COX2-A and
D-Alb oligonucleotides. The D-Alb oligonucleotide corre-
sponds to the D enhancer of the murine albumin promoter,
which binds C/EBP factors [33] (Fig. 2A, lanes 3±5). This
result confirms that the COX2-B and COX-2A elements bind
C/EBP family members. An antibody against C/EBPa did not
alter any of the B1 and B2 complexes (Fig. 2A, lane 6).
Because all the C/EBP family members have the same binding
site, rabbit articular chondrocytes probably do not produce
C/EBPa. Antibodies to C/EBPb and C/EBPd totally super-
shifted the B1 complex (Fig. 2A, lanes 7, 8). By contrast the B2
complex was only partially displaced by both these antibodies
(Fig. 2A, lanes 7 and 8). Considering that C/EBPb and C/EBPd
bind to DNA by forming heterodimers as well as homodimers,
these data indicate that the B1 complex is formed by C/EBPb±
C/EBPd heterodimers, while the B2 complex is heterogeneous
and corresponds to comigrating C/EBPb±C/EBPb and
C/EBPd±C/EBPd homodimers.
Mutation of the [2132; 2124] C/EBP binding sequence in a
CAT construct containing the [2261; 1103] fragment of the
COX-2 promoter suppressed the stimulation of the transcription
activity by IL-1b in primary culture chondrocytes (Fig. 2B).
Cotransfections of C/EBPb and C/EBPd expression vectors led
to enhancement of the activity of the wild type [2261; 1103]
promoter by 2.9 ^ 0.6 and 7.2 ^ 1.3-fold, respectively. Muta-
tion of the [2132; 2124] C/EBP binding site in the COX2-B
element did not affect the stimulation of the promoter activity
by C/EBPb or C/EBPd. However, as this mutation decreased
the basal promoter activity twofold, the transactivation of the
mutant promoter by C/EBPb and C/EBPd was also reduced
twofold (data not shown). Furthermore, the [281; 1103] frag-
ment of the promoter, which contains only the COX2-A
element and the TATA box, is still transactivated by C/EBPb
and C/EBPd (Fig. 2B). These results indicate that C/EBPb and
C/EBPd must bind to the COX2-B element for the transcription
of the human COX-2 gene to be stimulated by Il-1b in primary
cultures of chondrocytes; they also suggest that C/EBPb and
C/EBPd have alternative effects that might be mediated through
their binding to the COX2-A element.
Need for binding of USF and C/EBP family members to the
[271; 242] COX2-A element for the activity of the human
COX-2 promoter in primary cultures of rabbit chondrocytes
The COX2-A element formed three complexes with the chon-
drocyte nuclear extracts, A1, A2 and A3 (Fig. 3B, lane 1). The
A1 and A2 complexes migrated very close together and were
barely resolved. There was also a smeared band migrating just
below the A1 complex and superimposed on the A2 complex.
The intensities of the A1, A2 and A3 complexes were increased
when the cells were treated with IL-1b prior to extraction of the
nuclear proteins (Fig. 3B, compare lanes 1 and 2). The A2 and
A3 complexes were competed out by a 100-fold excess of the
unlabeled C/EBP binding oligonucleotide D-Alb (Fig. 3C, lane
2). The A2 and A3 complexes were supershifted by antibodies
against C/EBPb and C/EBPd, but not by antibodies to C/EBPa
(Fig. 3C, lanes 3±6), similarly to the B1 and B2 complexes
formed with the COX2-B element. This indicates that these
complexes corresponded to homodimers or heterodimers of
C/EBPb and C/EBPd, like the B1 and B2 complexes. The
formation of the A1 complex was prevented by adding a 100-
fold excess of the USF binding oligonucleotide and the anti-
body to USF1/2 (Fig. 3C, lanes 6 and 7). The [262; 250]
5 0-CATTTCGTCACAT-3 0 sequence must be responsible for the
formation of the A1 and A3 complexes, because their formation
was not impeded by adding a 100-fold excess of the unlabeled
oligonucleotide Am1, in which this sequence was mutated
(Fig. 3A and Fig. 3C, lane 8). Two oligonucleotides, Am2 and
Am3, which contain mutations of the 260/258 and 252/251
nucleotides, respectively, were also used as competitors to
localize the C/EBP and USF binding sites within the [262;
250] sequence (Fig. 3A,D). The A2 and A3 complexes were
competed out by the Am3 oligonucleotide, but not by Am2
(Fig. 3D, lanes 1 and 2). By contrast, the complex A1 was
competed out by the Am2 oligonucleotide, but not by Am3
(Fig. 3D, lanes 1 and 2). Finally, the smeared band migrating
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just below the A1 complex was not suppressed by 100-fold
excesses of C/EBP-binding or Am3 competitors (Fig. 3C and
Fig. 3D, lanes 2). These results indicate that the 260/258
nucleotides are critical for the binding of C/EBP family
members, which generate the A2 and A3 complexes. These
nucleotides are located just upstream of the putative ATF/CRE
sequence 5 0-CGTCAC-3 0 (Fig. 3A). They also show that the
[256; 251] 5 0-GTCACA-3 0 E-box-like sequence, which is
altered in the Am3 oligonucleotide, is involved in the binding
of USF.
Mutation of the whole [262; 250] sequence in the COX2-A
element suppressed the stimulation of the [2261; 1103]
promoter activity by IL-1b. It also suppressed the stimulation
of the promoter activity by exogenous C/EBPb and greatly
reduced that by C/EBPd (Fig. 4). Surprisingly, individual
mutations of the USF or C/EBP binding sites similar to those
performed in the Am2 and Am3 oligonucleotides did not alter
the induction by IL-1b. Transactivations by exogenous C/EBPb
and C/EBPd were slightly decreased by the Am2 mutation but
unaffected by the Am3 mutation (Fig. 4). Finally, the Am1,
Am2 and Am3 mutations did not significantly modify the basal
activity of the [2261; 1103] promoter (Fig. 4). Although
C/EBPb and C/EBPd bind to the COX2-A as well as to the
COX2-B elements, these results indicate that their binding to
these two elements have different consequences. The binding of
C/EBPb and C/EBPd to the COX2-B element is critical for
stimulation of the promoter activity by IL-1b, while C/EBP
factors can be replaced by USF on the COX2-A elements to
induce COX-2 gene transcription in chondrocytes. This aspect
of the regulation of the COX-2 gene transcription is further
discussed below.
NF-kB binds to the 2448/2439 and 2223/2214 sequences
of the human COX-2 promoter but the 2223/2224 sequence
is involved in the regulation of transcription by IL-1b in
chondrocytes
We identified the contribution of NF-kB to the stimulation of
the activity of the human COX-2 promoter in chondrocytes by
determining whether this factor actually bound to the putative
proximal and distal sites. NF-kB is formed by the association of
two subunits, p50 and p65. The p65 subunit supports a strong
transactivation ability but has a poor affinity for DNA, while
p50 binds strongly to DNA but is poorly active [35]. NF-kB is
translocated to the chondrocyte nuclei during the first hour of
Fig. 2. The [2140; 2116] COX2-B element binds C/EBPb and C/EBPd
factors and is critical for stimulation of COX-2 promoter activity by IL-1b
in chondrocytes. (A) The 5 0 end 32P labeled COX2-B probe (100 000 cpm)
were incubated with 3 mg poly(dI-dC) and 6 mg nuclear extracts of untreated-
(lane 1) or IL-1b treated chondrocytes (lanes 2±8). Primary cultures of rabbit
chondrocytes were incubated with 10 ng´mL21 IL-1b for 24 h prior to
extraction of nuclear proteins. 100-fold excesses of unlabeled COX2-B,
COX2-A, and D-Alb oligonucleotides over the COX2-B concentration were
incubated with the nuclear extracts for 15 min before adding the probe (lanes
3±5). The d-alb oligonucleotide corresponds to the regulatory element D of
the murine albumin promoter which binds the C/EBP family members.
Antibodies (1 mL pure commercial solution, Santa Cruz Inc, USA) against C/
EBPa (lane 6) C/EBPb (lane 7) or C/EBPd (lane 8) were incubated with
chondrocyte nuclear extracts for 15 min at 4 8C prior to adding poly(dI´dC).
NS indicates a nonspecific band. B1 and B2 complexes are indicated by
arrows. Electrophoresis was run on a 7% 30 : 1 bisacrylamide/acrylamide gel,
which was dried and autoradiographed overnight. (B) Rabbit chondrocytes
were transfected as indicated in Fig. 1 with the CAT constructs containing the
wild-type [2261; 1103] promoter, its mutant homolog for element B or the
wild-type [281; 1103] promoter. The mutations of the COX2-B elements are
indicated in the Materials and methods section. Cells were cultivated with or
without IL-1b (10 ng´mL21) as indicated in Fig. 1. The CAT construct were
cotransfected with 1 mg of the PHD expression vectors containing C/EBPb
(dotted bars) or C/EBPd (dashed bars) cDNAs. Stimulations of the CAT
activity were calculated relatively to that induced by the wild type or mutant
[2261; 1103] CAT constructs in the absence of treatment by IL-1b and
cotransfected C/EBP expression vector. Results are expressed as the means
^SEM of three independent experiments performed in duplicate.
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Fig. 3. The [271; 242] COX2-A element binds C/EBPb, C/EBPd and USF factors. (A) Sequences of the wild type COX2-A oligonucleotide and its
mutant COX2-Am1, COX2-Am2 and COX2-Am3. Dashes indicate the nucleotides unchanged in the mutant oligonucleotides. Nucleotides replacing the wild
type sequence are indicated. (B) The COX2-A probe (100 000 cpm) was incubated with 6 mg of untreated-(lane 1) or IL-1b-treated chondrocytes nuclear
extracts. (C) The COX2-A probe (100 000 cpm) was incubated with 6 mg of IL-1b-treated chondrocytes nuclear extracts. Unlabeled oligonucleotides D-Alb
(lane 2), USF (lane 6) or COX2-Am1 (lane 8) were added to the nuclear proteins in 100-fold excesses over probe concentration and incubated for 15 min
before adding the COX2-A probe. Specific antibodies to C/EBPa (lane 3) C/EBPb (lane 4), C/EBPd (lane 5) or USF (lane 7) were incubated with
chondrocyte nuclear extracts for 15 min at 4 8C prior to adding poly(dI´dC). (D) As in (C) the COX2-A probe (100 000 cpm) was incubated with 6 mg of
IL-1b-treated chondrocytes nuclear extracts. The unlabeled oligonucleotides COX2-Am2 (lane 1) or COX2-am3 (lane 2) were added to the nuclear proteins
in 100-fold excesses over probe concentration and incubated for 15 min before adding the COX2-A probe. The complexes A1, A2 and A3 are indicated by
arrows.
Fig. 4. Effects of mutations of the COX2-A
element on stimulation of the activity of the
human COX-2 promoter by IL-1b and C/EBP
family members in rabbit chondrocytes.
Primary cultures of rabbit chondrocytes were
transfected as indicated in Fig. 1 with the
wild-type [2261; 1103]wt and mutant
[2261; 1103]Am1, [2261; 1103]Am2 and
[2261; 1103]Am3 CAT constructs. Mutations
in the COX2-A elements in the mutant CAT
constructs are indicated in Materials and
methods. Cells were grown with or without
IL-1b (10 ng´mL21) as indicated in Fig. 1.
The CAT construct were cotransfected with
the PHD expression vectors containing C/EBPb
(dotted bars) or C/EBPd (dashed bars) cDNAs.
CAT activities were normalized by using
b-galactosidase activities. Results are expressed
as the means ^SEM of three independent
experiments performed in duplicate.
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stimulation by IL-1b, and its nuclear binding remains
unchanged for up to 24 h, as shown by bandshift experiments
using the enhancer of the light chain k gene as a probe (KBEwt
probe) (data not shown). The oligonucleotide corresponding to
the [2233; 2214] COX2-C element formed two complexes
with nuclear extracts from IL-1b-treated chondrocytes, the
major one having the higher electrophoretic mobility (Fig. 5A,
lane 1). The lower mobility complex was only partially
competed out by a 100-fold excess of unlabeled KBEwt
oligonucleotide, while the high mobility one was totally
displaced (Fig. 5A, lane 2). The higher mobility complex was
supershifted by an antibody to p50 but not by an antibody to
p65, indicating that it is formed by the p50/p50 homodimer
(Fig. 5A, lanes 3 and 4). By contrast, the lower mobility com-
plex was not afffected by incubating the chondrocyte nuclear
extracts with the antibodies against p50 and p65 (Fig. 5A, lanes
3 and 4). These results show that the lower mobility complex is
formed by a protein differing from the canonical p50 and p65
c-Rel family members. The oligonucleotide corresponding to
the [2455; 2433] COX2-D element also formed two com-
plexes with the chondrocyte nuclear extracts (Fig. 5B, lane 1).
Both these complexes were competed out by a 100-fold excess
of unlabeled KBEwt oligonucleotide (Fig. 5B, lane 2). The
upper complex must be generated by the p50/p65 heterodimer,
because it was supershifted by the antibodies to both p50 and
p65, while the lower one was supershifted only by the antibody
to p50 (Fig. 5B, compare lanes 3 and 4), indicating that this
complex was formed by the p50/p50 homodimer.
Various amounts of chondrocyte nuclear extract were
incubated with the COX2-C, COX2-D and KBEwt probes to
compare their affinity for NF-kB. The canonical KBEwt probe
bound mainly to the p50/p65 heterodimer (Fig. 6, lanes 1±4).
The complex formed between the KBEwt probe and the p50/
p65 heterodimer was much more intense than either of the
complexes formed between the COX2-D probe and 6±12 mg of
nuclear extracts from IL-1b-treated chondrocytes (Fig. 6,
compare lanes 2±4 to lanes 6±8). This result shows that the
COX2-D element has a low affinity for NF-kB, especially for
the transcriptionally active p50/p65 heterodimer. The COX2-C
probe bound only the p50/p50 homodimer in chondrocytes
nuclear extract concentrations of 6±12 mg (Fig. 6, lanes 9±12).
Mutation of the [2448; 2449] 5 0-GGGGATTCCC-3 0 NF-kB
site of the COX2-D element in the [2831; 1103] fragment of
the human COX-2 promoter did not modify the induction of
Fig. 5. The [2233; 2204] COX2-C element binds the p50/p50
homodimeric forms of NF-kB and a nonrel factor while the [-455;
2433] COX2-D element binds both the p65/p50 heterodimeric and p50/
p50 homodimeric forms. (A) Bandshift assays were performed as
described in Materials and methods. Primary cultures of rabbit chondro-
cytes were incubated with 10 ng´mL21 IL-1b for 24 h prior to extraction of
nuclear proteins. A 100-fold excess of unlabeled oligonucleotide KBEwt
over the COX2-C probe concentration was added to the nuclear proteins for
15 min before adding the COX2-C probe (lane 2). Antibodies (1 mL of pure
stock solution) against p50 (lane 3) or p65 (lane 4) were incubated with
chondrocytes nuclear extracts for 15 min at 4 8C prior to adding
poly(dI´dC). The complexes formed with the p50/p50 homodimeric form
of NF-kB and the nonrel protein are indicated by the arrows. Ssp50
indicates the supershifted complexes in presence of the antibody to p50
(lane 3). Non-specific bands are indicated by asterisks. Electrophoresis was
run on a 5% 30 : 1 bisacrylamide/acrylamide gel. (B) Bandshifts assays
were performed as described in (A). A 100-fold excess of unlabeled
oligonucleotide KBEwt over the COX2-D probe concentration was added to
the nuclear proteins for 15 min before adding the COX2-D probe (lane 2).
Antibodies (1 mL of pure stock solution) against p50 (lane 3) or p65 (lane
4) were incubated with chondrocyte nuclear extracts for 15 min at 4 8C
prior to adding poly(dI´dC). The complexes formed with the p50/p65
heterodimer and the p50/p50 homodimer are indicated by arrows. Ssp50
and Ssp65 indicate the supershifted complexes in the presence of the
antibodies to p50 and to p65, respectively. Non-specific bands are indicated
by asterisks.
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transcription by IL-1b in primary cultures of rabbit chondro-
cytes (Fig. 7). By contrast, mutations of the [2223; 2214] 5 0-
GGGACTACCC-3 0 NF-kB site of the COX2-C element in the
[2831; 1103] and [2261; 1103] fragments of the COX-2
promoter suppressed the stimulation of their activities by IL-1b
in primary cultures of rabbit chondrocytes (Fig. 7). This
indicates that, although it does not bind the transcriptionally
p50/p65 active form of NF-kB, the COX2-C element plays a
critical role in the regulation of the human COX-2 promoter by
IL-1b in primary cultures of chondrocytes, in addition to the
the C/EBP binding COX2-B element.
D I S C U S S I O N
We have shown that C/EBPb and C/EBPd factors bind to the
COX2-B element in chondrocyte primary cultures and that this
binding is required for stimulation of the COX-2 promoter by
IL-1b in chondrocytes, as both the 5 0 deletion and the mutation
of this sequence suppressed the effect of IL-1b. We have pre-
viously shown that IL-1b stimulates expression of the C/EBPd
gene without affecting that of the C/EBPb gene [25]. Enhance-
ments of the intensities of the complexes formed with the COX2-
B probes in bandshift experiments are likely to be due to the
increased C/EBPd protein bound to DNA, either as a homo-
dimer or a heterodimer with C/EBPb. Such critical roles for
C/EBPb and C/EBPd have been recently described by
Wadleigh et al. [10] in the induction of the mouse COX-2
promoter activity by LPS in RAW 264.7 macrophages. These
Fig. 6. The [2233; 2204] COX2-C and [2455; 2433] COX2-D elements have less affinity for NF-kB than the canonical KBEwt probe
corresponding to the enhancer of the light chain k gene. The 5 00 end 32P labeled KBEwt (lanes 1±4), COX2-D (lanes 5±8) and COX2-C (lanes 9±12)
probes (100 000 cpm) were incubated with 3 mg poly(dI-dC) and 6 mg nuclear extracts of untreated chondrocytes (lanes 1, 5 and 9) or 6±12 mg (lanes 2±4,
6±8, 10±12) of IL-1b treated chondrocytes as indicated at the top of the figure. The complexes formed with the p50/p65 heterodimeric and p50/p50
homodimeric forms of NF-kB or with the nonrel protein are indicated by the arrows. Non-specific bands are indicated by the asterisk. Electrophoresis was run
on a 6% 30 : 1 bisacrylamide/acrylamide gel.
Fig. 7. Stimulation of the human COX-2 promoter by IL-1b in rabbit
chondrocytes involves the p50/p50 homodimeric form of NF-kB bound
to the COX2-C element. Rabbit chondrocytes were transfected as in Fig. 1
with the wild-type [2831; 1103] wt, [2261; 1103]wt CAT constructs or
the mutant mutD [2831; 1103], mutC [2831; 1103] and mutC
[2261; 1103] CAT constructs. The NF-kB site in the COX2-D element
was mutated in the mutD [2831; 1103] CAT construct as indicated in
Materials and methods. Similarly, the mutation of the COX2-C element in
mutC [2831; 1103] and mutC [2261; 1103] CAT constructs are
indicated in Materials and methods. Stimulations of the CAT activities by
IL-1b were calculated relative to that induced by the corresponding CAT
construct in the absence of treatment by IL-1b. Results are expressed as the
means ^SEM of three independent experiments performed in duplicate.
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authors found two C/EBP binding sequences, one correspond-
ing to the human distal site, the other located between the 2138
and 2130 positions [10]. The alteration of the first one reduced
more drastically the induction of the promoter activity than the
second one and mutations of both these sequences was required
to abolish the endotoxin effect. These authors also demon-
strated that a CRE sequence in a proximal element correspond-
ing to the human COX2-A element is critical for the basal and
stimulated activity of the mouse promoter while the adjacent
E-box does not contribute to the transcription activity in RAW
264.7 macrophages [10].
We found no evidence of the presence of any C/EBP binding
site in the human promoter between the COX2-B and COX2-A
elements and deletion of the [2170; 281] fragment did not
alter the activity of the human promoter in chondrocytes. By
contrast, we demonstrated the binding of native C/EBPb and
C/EBPd proteins to the COX2-A element in chondrocytes.
Inoue et al. [13] also reported the binding of C/EBPd to this
element, but they used nuclei of vascular endothelial cells
transfected by a C/EBPd expression vector instead of nuclear
extracts of native cells in their bandshift experiment. The binding
of endogenous vascular endothelial nuclear proteins to the
proximal regulatory element of the COX-2 promoter could have
been prevented by the overproduced C/EBPd in these experi-
ments. In addition, bandshift experiments also demonstrated USF
binding downstream of the C/EBP site in chondrocytes,
although Morris and Richards [19] assumed that the COX2-A
element of the human promoter would not bind USF family
members because of a 1-bp mutation in the E-box compared
with the homologous fragment of the rodent promoters. In
contrast to the results obtained by Wadleigh et al. [10], the
second C/EBP binding site, i.e. the COX2-A element, is not
involved in the stimulation of the human promoter activity by
IL-1b in chondrocytes. Surprisingly, exogenously expressed
C/EBPb and C/EBPd factors stimulate the activity of mutant
fragments of the COX-2 promoter lacking the COX2-B element
but containing the COX2-A element. Furthermore, separated
mutations of the C/EBP and USF binding sites in the COX2-A
element did not alter the stimulation of the transcription activity
by IL-1b or exogenously expressed C/EBP factors in chondro-
cytes while the mutation of both the sites, i.e. the Am1 muta-
tion, drastically reduce these stimulations. We postulate that:
(a) C/EBP factors bound to the COX2-B and COX2-A elements
interact differently with the general transcriptional machinery;
(b) the C/EBP and USF factors bound to the COX2-A element
have complementary roles and may work together to transacti-
vate the COX-2 promoter. USF factors regulate the transcription
activity of the eukaryotic promoter through their interactions
with components of the general transcription factors such as
TFII-I [36] and TFII-D [37]. Interactions of C/EBPb with
TFII-B, another component of the transcription general
machinery, has also been reported either as a direct interaction
[38], or as an indirect interaction mediated by the nucleolar
Nopp140 coactivator [39]. Multiple interactions between the
numerous components of the general transcription machinery
and the transcription factors bound to the proximal regions of
Fig. 8. Postulated interactions between the transcription factors bound to the regulatory elements of the human COX-2 promoter and the general
transcription factors bound to the TATA box.
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the promoter is the usual way of inducing high transcription
activity. Alternative interactions of USF and C/EBP factors
bound to the COX2-A element with different subunits of the
general transcription machinery would explain why mutations
of both the USF and C/EBP binding sites are required to
decrease the basal promoter activity and to abolish its stimu-
lation by IL-1b. In addition, exogenously expressed C/EBP
factors could stimulate the activity of the promoter fragments
containing the COX2-A element by increasing the number of
interactions with components of the general transcription
machinery. The location of the COX2-A element, 24 bp
upstream of the TATA box, favors such direct interactions of
C/EBP and USF factors with the general transcription
machinery. By contrast, such interaction of the C/EBP proteins
bound to the far upstream COX2-B element is unlikely and
these C/EBP proteins might transactivate the COX-2 promoter
in response to IL-1b through their interaction with the CBP/
p300 coactivator [40]. IL-1b might not only increase the
concentration of C/EBPd as we previously demonstrated [25]
but also qualitatively modify the interactions between C/EBP
factors and CBP/p300. This could be mediated through post-
translational modifications of CBP/p300 such as phosphory-
lations by MAP kinases, which have been previously evidenced
[41]. Such hypothesis could explain why the COX2-B element
is required for the stimulation of the human COX-2 promoter
by IL-1b and the COX2-A element is not sufficient for this
stimulation although it could be transactivated by exogenously
expressed C/EBP factors. The possible regulatory mechanisms
of the various factors that bind to the human COX-2 promoter
are summarized in Fig. 8.
Many eukaryotic promoters, such as those of interleukin-8
[42], serum amyloid A [43], interleukin-6 [44], nitric oxide
synthase [45], intercellular adhesion molecule-1 (ICAM) [46]
or manganese superoxide dismutase [47] genes, are regulated
through interactions between NF-kB and C/EBP factors. In
most cases, these interactions involve p65. In chondrocytes, p50
but not p65 is implicated in the regulation of human COX-2
transcription by IL-1b. The present results show that the distal
[2448; 2439] sequence in the COX2-D element binds the p50/
p65 heterodimer and the p50/p50 homodimer with a low
affinity and that the proximal [2223; 2214] sequence on the
COX2-B element binds only the p50/p50 homodimer. Although
it has not been previously reported in the cell types in which the
regulation of the COX-2 promoter has been studied, this is
consistent with the fact that the 3 0 ends of the [2448; 2439]
5 0-GGGGATTCCC-3 0 and [2223; 2214] 5 0-GGGACTACCC-
3 0 sequences do not fit with the perfect consensus binding site
of NF-kB, such as the 5 0-GGGACTTTCC-3 0 sequence in the
KBEwt oligonucleotide. The 5 0 end of such a sequence is
recognized by the p50 subunit, whereas the 3 0 end is recognized
by the p65 subunit or another p50 monomer [48]. Fujita et al.
[35] reported that alteration of the 3 0 end sequence decreases
the affinity for the p50/p65 heterodimer much more drastically
than its affinity for the p50/p50 homodimer. The formations of
complexes with the homodimer p50/p50 are therefore favored
in vitro when the 3 0 end of the binding sequence is degenerated
compared to the consensus site. Mutation of the COX2-C
element suppressed the stimulation of the promoter activity by
IL-1b although this element does not bind to the p50/p65
heterodimer but only to the p50/p50 homodimer. There are
physical interactions between p50 and C/EBP factors [49±51]
that would explain the requirement of both the COX2-B and
COX2-C element for full stimulation of the human COX-2
promoter activity by IL-1b. The COX2-C elements also formed
a faint complex with the chondrocyte nuclear extract, which
was not altered by antibodies against p50 or p65. This complex
was also observed by Crofford et al. [9] with nuclear extracts
from IL-1b-treated human synoviocytes and by Schmedtje et al.
[7] with nuclear extracts from hypoxemic human vascular
endothelial cells but these authors did not further investigate the
nature of the protein involved in its formation. matinspector
sofware and the transfac database [52] revealed homologies
between the COX2-C element and consensus sites for several
transcription factors, notably for the MZF1 factor, whose
recognition site fits perfectly with the [2227; 2 220] 5 0-
AGTGGGGA-3 0 sequence in this element. This factor, first
described as lymphoid-specific [53], has been poorly studied.
Additional studies will be required to determine the identity of
the protein generating the low mobility complex with COX2-C
element and its role in the regulation of the COX-2 promoter
activity.
Increased synthesis of PGE2 by chondrocytes and synovio-
cytes in response to IL-1b is a key event in the inflammatory
process in joints. PGE2 is produced through the interaction
between COX-2 and sPLA2 in cell types that express both
these genes in response to stimulation by IL-1b [54,55]. As a
consequence, blocking the expression of both these genes
would reduce PGE2 production, inflammation and the resulting
degradation of cartilage. We have shown [25] that C/EBPb and
C/EBPd are responsible for inducing sPLA2-IIA transcription
in primary culture chondrocytes. The present paper demon-
strates that these factors coregulate the COX-2 transcription in
these cells. These transcription factors are therefore potential
targets for anti-inflammatory therapy in joints.
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